Company intelligence / Profile preview

Labatec Pharma

Geneva, Geneva, Switzerlandlabatecpharma.com ↗

Ownership: Private
Employees: ~139
Development stage: Commercial

Overview

Labatec Pharma has a commercial portfolio of over 65–100 products across hospital and retail sectors in Europe and emerging markets. The company supplies critical anti-tuberculosis drugs such as ethambutol ("Myambutol"), rifampicine ("rifampicin"), pyrazinamide and isoniazid—some under assessment by the World Health Organization for prequalification. These are listed on the Global Fund Anti-TB list of pharmaceutical suppliers. The company also manufactures its own musculo-skeletal and TB treatments in the EU.

Therapeutic areas: RheumatologyOphthalmologyOtherWomen's HealthOncologyInfectious Diseases
Modalities: Small molecule
Industry: Biotech

Drug pipeline

3 assets

BACLOCALM

Unknown

2 more assets in the full pipeline.

Request access →

Partnerships

Supplies to Swiss hospitals/pharmacies for TB drugsListed supplier to Global Fund Anti-TB program

Beyond the preview

Go deeper on Labatec Pharma.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Labatec Pharma.

Explore the full profile